Pediatric Orthopedic Implants Market Growth Report | Global Forecasts to 2030

The pediatric orthopedic implants market size was valued at US$ 3,812.77 million in 2022 and is projected to reach US$ 8,502.17 million by 2030. It is estimated to register a CAGR of 10.5% during 2022–2030.

Market Insights and Analyst View:

The pediatric orthopedic implants market size is flourishing with the increase in the number of pediatric surgeries performed to treat orthopedic birth defects and growing access to pediatric orthopedic treatments. A surge in the use of biodegradable implants instead of polymer and ceramic-based implants due to their high quality is further fueling the growth of the pediatric orthopedic implants market.    

Researchers working on orthopedic implants mainly focus on improving the quality of life for patients. They are harnessing modern, competitive technologies to produce more affordable medical implants. For instance, in March 2023, NuVasive, Inc., a leader in spine technology innovation, received the US Food and Drug Administration’s (FDA) 510(k) clearance for the extended applications of its Precice all-internal limb lengthening solution to pediatric patients. Precice is a magnetically adjustable technology that utilizes an external remote to noninvasively lengthen implants. Precice nail has been implanted in more than 50 countries by more than 2,000 surgeons. Thus, a significant rise in revolutionary technologies to address customer needs is likely to bring new trends in the market during the forecast period.

Growth Drivers and Challenges:

Orthopedic defects are acquired or congenital abnormalities that affect the muscles, skeleton, and related tissues. These abnormalities predominantly result in muscle imbalance, paralysis, and decreased sensation in the lower extremity. The congenital orthopedic disabilities include clubfoot, spine deformities, osteogenesis imperfecta, muscular dystrophy, limb defects, and bone infections. Developmental dysplasia leading to hip dislocation and metatarsus adducts causing curved foot or in-toeing are also categorized as congenital orthopedic disabilities.

An increase in the prevalence of orthopedic birth defects drives the growth of the pediatric orthopedic implants market. According to the Centers for Disease Control and Prevalence (CDC), clubfoot is one of the most common birth defects in the US; it affected ~6,643 babies in the country in 2022. Abnormal genes inherited from a parent and chromosomal disorders leading to missing or abnormal traits in offspring are among the notable causes of orthopedic birth defects. Moreover, the availability of tools and technologies that support the early diagnosis and treatment of these disorders contribute to better patient outcomes, in turn, bolstering the adoption of pediatric orthopedic implants. Additionally, pediatric trauma cases have increased over the past decade. According to an article published in Cureus, factors such as a surge in outdoor activities among children and the growing number of accidental injuries continue to boost the prevalence of pediatric trauma, which would continue to benefit the pediatric orthopedic implants market in the coming years.

Medical implants are not always appropriate for children due to the fixed sizes of these components in contrast to the biological tendency of the children’s bodies to grow in size. Hence, these implants need to be replaced at some point, subjecting pediatric patients to the trouble of multiple surgeries. Additionally, the implant removal process may cause the risk of refracture. According to an article published in the Spanish Journal of Orthopedic Surgery and Traumatology in 2021, in Spain, cerclage in the patella and olecranon is the most common indication for orthopedic implants in children. Routine implant removal is standard procedure post-implant operations, and approximately 31% of patients prefer removing implants to avoid possible complications. Implant infection, breakage, loosing, etc., are some other common hurdles associated with orthopedic implants, which limit the use of medical implants, thereby hindering the growth of the pediatric orthopedic implants market.  

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Pediatric Orthopedic Implants Market: Strategic Insights

Market Size Value in	US$ 3,812.77 million in 2022
Market Size Value by	US$ 8,502.17 million by 2030
Growth rate	CAGR of 10.5% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Report Segmentation and Scope:

The pediatric orthopedic implants market is divided on the basis of type, application, and end user. Based on type, the pediatric orthopedic implants market is classified into hip implants, spine implants, knee implants, dental implants, craniomaxillofacial implants, and others. Based on application, the pediatric orthopedic implants market is segmented into trauma & deformities, broken bones, bone and joint infection, spinal deformities, and others. In terms of end user, the pediatric orthopedic implants market is segmented into hospitals, pediatric clinics, and others. Based on geography, the market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

Based on type, the pediatric orthopedic implants market is segmented into hip implants, spine implants, knee implants, dental implants, craniomaxillofacial implants, and others. In 2022, the hip implants segment held the largest share of the market. The knee implants segment is expected to record the fastest CAGR during 2022–2030. Hip implants relieve pain and restore mobility associated with hip diseases and arthritis. Inflammation, hip fracture, and natural wear-and-tear are common reasons for hip replacement surgery. Orthopedic hip implants are commonly used in pediatric patients to treat traumatic injuries and developmental hip dysplasia. Total hip replacement in the pediatric population requires a broad array of additional considerations because of the age and functional demands of these patients. Hip implants are commonly used during the treatment of patients diagnosed with hip dysplasia. In the US, 1 in 1,000 babies is born with hip dysplasia annually. Thus, the increasing incidence of hip dysplasia is anticipated to drive the pediatric orthopedic implants market growth for the hip implants segment. However, total hip arthroscopy is rarely recommended in children, which limits the use of hip implant products and hinders the market growth to some extent.

Juvenile idiopathic arthritis (JIA) that causes swelling and stiffness in joints is a form of arthritis that is common in children. Durable knee implants play an important role in the management and treatment of JIA. Joint replacement offers dramatic benefits for the treatment of JIA. For instance, the incidence rate estimates for JIA range from 4 to 14 cases per 100,000 children annually in the US. Increasing participation in youth sports may increase the risk of knee injuries in children. According to the American Academy of Pediatrics (AAP), anterior cruciate ligament (ACL) tears in kids aged 6–18 have increased by about 2.3% each year over the past 20 years.

Pediatric Orthopedic Implants Market, by Type – 2022 and 2030

Access Data

Based on application, the pediatric orthopedic implants market is classified into trauma and deformities, broken bones, bone and joint infection, spinal deformities, and others. In 2022, the trauma and deformities segment held the largest share of the market. It is further expected to register the highest CAGR during 2022–2030. The line of treatment of pediatric orthopedic trauma and deformities is evolving worldwide due to congenital diseases, developmental disorders, or acquired problems. Nonprofit organizations are taking initiatives to improve clinical outcomes and improve the management of orthopedic trauma in children. For instance, Children’s Hospital Colorado works closely with a multidisciplinary team appointed at the Orthopedics Institute, including orthopedic surgeons, rehabilitation providers, plastic surgery providers, and infectious disease specialists, to provide comprehensive care and ensure the best possible outcome for children. Moreover, congenital deformities involving the skeleton represent a major healthcare burden in Europe and other countries. According to the European Platform on Rare Disease Registration, the prevalence of skeletal dysplasia was 2 cases per 10,000 births in 2021 in Europe.

Based on end user, the pediatric orthopedic implants market is classified into hospitals, pediatric clinics, and others. In 2022, the hospitals segment accounted for the largest share of the market. The market for this segment is estimated to grow at a significant CAGR during 2022-2030. An orthopedic hospital is a medical facility focusing on diagnosing, treating, and managing musculoskeletal diseases and injuries. Due to the availability of advanced technologies and facilities, orthopedic hospitals are usually preferred for hip replacement, spine surgery, fractures, etc. Moreover, public and private hospitals are taking initiatives to improve and expand clinical services through partnerships and collaborations. In November 2022, NCH Healthcare System partnered with the Hospital for Special Surgery based in New York. In March 2021, CarePoint Health (a continuous provider of health care) collaborated with Rothman Orthopaedic Institute (a world leader in the field of orthopedics serving communities in Pennsylvania) to establish a comprehensive orthopedic services institute at Hoboken University Medical Center and Christ Hospital in Jersey City. This collaboration helps develop and enhance a broad array of high-quality orthopedic programs for medical, surgical, and related issues. Moreover, this collaboration expanded the availability of these clinical services in Hudson County and ensured access to convenient, patient-centered orthopedic care.

Regional Analysis:

Based on geography, the pediatric orthopedic implants market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the market, and Asia Pacific is expected to be the fastest-growing market in the coming years. The market growth in North America is attributed to the increasing cases of birth deformities and the rising implementation of growth strategies by key market players operating in this region. In addition, the growing health expenditures in major countries would drive market growth in the region during the forecast period. The US has a large number of clinics providing advanced surgical services, wherein the number of orthopedic surgeries performed is increasing notably. The World Health Organization (WHO) states road traffic injuries as the 8th leading cause of death among pediatric individuals. According to the Centers for Disease Control and Prevention (CDC), ~9.2 million children in the US are admitted to the emergency department for the treatment of accidental injuries such as falls and road traffic. The increasing number of traumatic injuries and road accidents, and the rising prevalence of congenital or acquired face deformities, coupled with technological advancements in plastic surgery procedures, contribute to the pediatric orthopedic implants market in the US. The Federal and state governments in the country offer various funds and support for orthopedic procedures. For instance, the Orthopaedic Research Program (US) supports clinical, epidemiological, and research outcomes in orthopedics and musculoskeletal rehabilitation. The funded studies focus on the preclinical testing and development of orthopedic devices/implants, human subject implant wear, and osteolysis.

Industry Developments and Future Opportunities:

Various initiatives by key players operating in thePediatric Orthopedic Implants Market are listed below:

1. In January 2021, OrthoPediatrics Corp. launched its first sterile-packed implant for the Pediatric Nailing Platform FEMUR (PNP|FEMUR).
2. In August 2020, WISHBONE MEDICAL, INC. acquired assets of Back 2 Basics Direct and Orbbö Surgical. The two privately held medical device companies focused on R&D and commercialization of sterile packaged implants and surgical instruments for spinal fusion

Competitive Landscape and Key Companies:

A few of the prominent players operating in the pediatric orthopedic implants market are Johnson & Johnson, Arthrex Inc., Stryker Corp, OrthoPediatrics Corp, WishBone Medical Inc., Samay Surgical Pvt Ltd., Vast Ortho Pvt Ltd., Merete GmbH, and Suhradam Ortho. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide as well as to increase their product range in specialty portfolios. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.